Search

everythinglearnresearchcommunity

for

Search:↓

Electrospun nanofibers might be a promising new treatment for hair loss.

Dexamethasone affects hair growth by altering levels of proteins that either promote or inhibit hair follicle growth.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Chitosan-decorated finasteride nanosystems improve skin retention and could be a better treatment for hair loss.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Certain cells from hair follicles can create new hair and contribute to hair growth when implanted in mice.

Acne treatment with isotretinoin increases the presence of p53, a protein, in skin and oil glands, which may help reduce acne severity.

Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.

Alopecia areata may be linked to heart issues.

Extracellular vesicles may effectively treat hair loss with minimal side effects.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Different PCOS types respond uniquely to infertility treatments, with some having lower pregnancy rates and higher risks of complications.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Sex hormones affect brain injury differently in males and females.

SHBG may be a useful early indicator and treatment target for PCOS.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Low dose cyclical nutrition therapy can consistently and safely improve hair growth and density without needing anti-androgens.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

Ayurvedic treatment, exercise, and a healthy diet can effectively manage PCOD symptoms.

Aging in hair follicle stem cells leads to hair graying, thinning, and loss.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

FP-1 is a key protein in rat hair growth, active only during the growth phase.